Multiple myeloma trials in Lithuania

1 of 2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study

  Where

  Vilnius

  Age

  18 years to 75 years

  People

  176 worldwide

  Run by

  Oslo University Hospital

  See details and how to joinNCT04513639 · EU 2023-510215-18-00